Brain Tumors Overview Updated
Most primary cancers of the central nervous system -- those of the brain and spinal cord -- are defined according to the type of cells from which they arise. The two most common primary brain tumors in adults are high-grade, or malignant, gliomas, which arise from the cells that surround and support the brain's nerve cells, and meningiomas, which are low-grade, noncancerous, tumors that begin in the membranes that line the skull and cover the brain. In this section, you can find information about our expertise in treating adults with tumors of the central nervous system, our services, and our research.
Neuroblastoma Overview Updated
Neuroblastoma is a rare cancer of the sympathetic nervous system -- a nerve network that carries messages from the brain throughout the body. Each year there are about 650 new cases in the United States, usually developing in young children. In this newly expanded section, you can find information about symptoms, diagnosis, staging, treatment, clinical trials, and survivorship, as well as patient stories and our expertise in treating patients with neuroblastoma.
New Study Examines Effectiveness of Colorectal Cancer Screening Tests and Suggests Screening May Be Stopped at Age 75
New findings from a Decision Analysis for the US Preventative Services Task Force suggest that routine colorectal cancer screenings can be stopped in patients over the age of 75. The results are based on patients who began screenings at age 50 and have had consistently negative screenings up to the age of 75, according to lead author Ann Graham Zauber, PhD, Associate Attending Biostatistician in the Department of Epidemiology and Biostatistics at Memorial Sloan-Kettering Cancer Center, and colleagues.
Brain Tumor Survivor Story
Colleen had surgery for a low-grade oligodendroglioma -- a rare, slow-growing tumor that begins in the cells that cover and protect nerve cells in the brain and spinal cord -- at Memorial Sloan-Kettering. She is running in the ING New York City Marathon to raise money for the Brain Tumor Center at Memorial Sloan-Kettering.
Neuroblastoma Patient Story
Emily Wang was diagnosed at the age of two with a rare childhood cancer known as neuroblastoma. Three days before completing her orginal treatment, doctors discovered that the cancer had spread to her brain.
Major Trends in Modern Cancer Research
On November 6, four of Memorial Sloan-Kettering's leading researchers highlight current trends in cancer research, explaining how the latest developments in various areas of science contribute to better treatments for cancer patients.
Survivor Web Casts
The following are recently added Web casts of selected meetings, lectures, and discussions designed to assist in adjustment to life after cancer treatment.
The Everything Talk: Pain, Fatigue, Hot Flashes, and More
More and more patients are living long past their cancer experience. But survivorship may be marked by a number of uncomfortable after-effects of treatment. In this Web cast, learn how to cope with these challenges, and improve your quality of life.
Longstanding Side Effects of Breast Cancer Treatment
For many breast cancer survivors, side effects from treatment can present ongoing questions and concerns. In this Web cast, nurse practitioners from Memorial Sloan-Kettering's breast cancer survivorship clinics will address common issues such as physical changes and hormonal shifts.
Longstanding Side Effects of Lung Cancer Treatment
For many lung cancer survivors, side effects from treatment can present ongoing questions and concerns. In this Web cast, Amy Logue, nurse practitioner from the lung cancer survivorship clinic, will address common issues for survivors.
About Herbs, Botanicals & Other Products
Presented by our Integrative Medicine Service, these pages provide evidence-based information about herbs, botanicals, supplements, and more.
